期刊文献+

急性冠脉综合征患者血浆肾素-血管紧张素-醛固酮系统活性测定意义 被引量:3

Renin-angiotensin-aldosterone system activity in patients with acute coronary syndrome
下载PDF
导出
摘要 目的:通过测定急性冠脉综合征(ACS)患者血浆肾素活性(PRA)、血管紧张素Ⅱ(AngⅡ)、醛固酮(Ald)水平,探讨其在ACS发生发展过程中的意义及对预后的影响。方法:采用放射免疫法分别检测22例不稳定性心绞痛(UA)、18例非ST段抬高型心肌梗死(NSTEMI)及28例ST段抬高型心肌梗死患者(STEMI)、11例健康者的血浆PRA、AngⅡ、Ald浓度,记录4周内所有患者的病情转归情况。结果:UA、NSTEMI、STEMI三组PRA、AngⅡ、Ald水平均明显高于健康对照组(P<0.05),组间相互比较均有统计学差异(P<0.05)。结论:肾素-血管紧张素-醛固酮系统活性水平与ACS的发生发展有关,并且与病情的严重程度呈正相关,对预后有重要的预测价值。 Objective:To investigate the clinical significance of renin-angiotensin-aldosterone system(RAAS) activity in the occurrence,development and prognosis of acute coronary syndrome(ACS).Methods:The plasma concentrations of renin,angiotensin and aldosterone were measured by radioimmunoassay in 22 patients with unstable angina pectoris(UA),18 with non-ST-segment elevation myocardial infarction(NSTEMI),28 with ST-segment elevation myocardial infarction(STEMI) and 11 healthy subjects.The treatment outcome was recorded in 4 weeks.Results:The plasma renin,angiotensin and aldosterone levels in UA,NSTEMI and STEMI groups were significantly higher than those in healthy control group(P0.05).There were significant differences in plasma renin,angiotensin and aldosterone levels among the groups(P0.05).Conclusion:The plasma RAAS activity level is related with the occurrence and development of ACS and is positively related with the severity of disease,indicating significant predictive value for the prognosis of ACS patients.
出处 《西北国防医学杂志》 CAS 2010年第3期192-194,共3页 Medical Journal of National Defending Forces in Northwest China
关键词 急性冠脉综合征 肾素-血管紧张素-醛固酮系统 预后 Acute coronary syndrome Renin-angiotensin-aldosterone system Prognosis
  • 相关文献

参考文献7

二级参考文献77

  • 1王文,马丽媛,李卫,吴海英.ACE抑制剂降压治疗对心脑血管事件影响的随机临床试验的汇总评估[J].高血压杂志,2005,13(4):202-208. 被引量:14
  • 2[2]Schieffer B,Schieffer E,Hilfiker-Kleiner D,et al.Expression of angiotensin Ⅱ and interleukin-6 in human coronary atherosclerotic plaques:potential implications for inflammation and plaque instability[J].Circulation,2000,101:1372-1378.
  • 3[4]Dzau VJ.Tissure angiotensin and pathobiology of vascular disease:a unifying hypothesis[J].Hypertension,2001,37:1047-1047.
  • 4Johnston CI, Risvantis J.Preclinical pharmacology of angiotensin Ⅱ receptor antagonists: update and outstanding issues. Am J Hypertens, 1997, 10 : 306S-10.
  • 5Aldermann MH, Madhavan S, Ooi WL, et al. Association of the renin-sodium profile with the risk of myocardial in farction inpatients with hypertension. N Engl J Med, 1991, 324: 1098--104.
  • 6Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature, 1992, 359:641--4.
  • 7Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE Inhibitor Myocardial Infarction Collaborative Group. Lancet, 2000, 355: 1575--81.
  • 8ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100.000 patients in randomized trials. Circulation, 1998,97: 2202--12.
  • 9Yusuf S, Sleight P, Pogue J, et al.Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000,342: 145-- 53.
  • 10Lonn E, Yusuf S, Dzavik V, et al. Effec'Ls of ramiprial and vitamin E on atherosclerosis : the study to evaluate carotid ultrasound changes in patients treated wish ramipril and vitamin E(SECURE). Circulation, 2001, 103:919--25.

共引文献44

同被引文献14

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部